Publications by authors named "Lisa Lowry"

Claim this Profile
I
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Ann Tivey, Rohan Shotton, Toby A Eyre, David Lewis, Louise Stanton, Lisa Lowry

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective multiparametric CMR characterization and MicroRNA profiling of anthracycline cardiotoxicity: A pilot translational study.
Iwan Harries, Giovanni Biglino, Kerrie Ford, Martin Nelson, Gui Rego, Lisa Lowry

Int J Cardiol Heart Vasc· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Muhammad Bilal Abid, Rachel Peck, Muhammad Abbas Abid, Wesam Al-Sakkaf, Yuening Zhang, Lisa Lowry

Hematol Oncol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenic rupture following temporary cessation of ibrutinib.
David Dutton, Huw Roach, Lisa Lowry

Br J Haematol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral optic neuropathy associated with Castleman disease.
Simon J Epps, Lisa Lowry, Catherine M Guly

Br J Haematol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age disparities in survival from lymphoma and myeloma: a comparison between US and England.
Dianne Pulte, Maria T Redaniel, Lisa Lowry, Jenny Bird, Mona Jeffreys

Br J Haematol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial.
Kirit M Ardeshna, Wendi Qian, Paul Smith, Nivette Braganca, Lisa Lowry

Lancet Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Has single-agent rituximab replaced watch-and-wait for a patient with asymptomatic low-grade follicular lymphoma?
Lisa Lowry, Kirit M Ardeshna

Cancer J· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors affecting survival in patients aged 60 and over with diffuse large B cell lymphoma failing first-line therapy.
Lisa Lowry, Paul Smith, David Cunningham, David C Linch

J Geriatr Oncol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL.
Sally Moore, Irfan Kayani, Karl Peggs, Wendi Qian, Lisa Lowry

Br J Haematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation remains beneficial for patients relapsing after R-CHOP chemotherapy and who respond to salvage chemotherapy.
Sally Moore, Karl Peggs, Kirsty Thomson, Lisa Lowry, Antonia Ljubic

Br J Haematol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial.
Lisa Lowry, Paul Smith, Wendi Qian, Stephen Falk, Kim Benstead

Radiother Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.
Sajir G Mohamedbhai, Keith Sibson, Teresa Marafioti, Irfan Kayani, Lisa Lowry

Br J Haematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developments in the management of Hodgkin's lymphoma.
Lisa Lowry, Peter Hoskin, David Linch

Lancet· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized comparison of the stanford V regimen and ABVD in the treatment of advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244.
Peter J Hoskin, Lisa Lowry, Alan Horwich, Andrew Jack, Ben Mead

J Clin Oncol· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 38: central nervous system lymphoma in a patient previously treated for Wegener's granulomatosis.
Lisa Lowry, Thomas Cairns, Maria Thom, Barbara J Bain

Leuk Lymphoma· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis